CompletedNCT00709202
Betahistine or placebo for antipsychotic-related weight gain
About this title
Read the official source — NCT00709202Medication studyAges 18–59United StatesBipolarity
Understand this study
Who was this study for?
Listed age limits: 18 years to 59 years.
- Listed locations
- OrangeburgSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJuly 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 48
- Sponsor
- Nathan Kline Institute for Psychiatric Research
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 59 Years
- Official registry ID
- NCT00709202
- Official title
Show the full official title
The Attenuation of Second Generation Antipsychotic Induced Weight Gain in Adolescents and Adults Using Betahistine: A Double-Blind, Placebo-Controlled Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Orangeburg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Nathan Kline Institute for Psychiatric Research, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Betahistine and Placebo Oral Tablet.
Who was this study for?
Listed age limits: 18 years to 59 years.
